Clinical trial Recruiting at 1 site Observational Ages 18 and up Women only

Atypical Endometriosis: Histology, Immunophenotype and Molecular Features

Official title: Endometriosis "Atypical" and Cancerized: Anatomopathological and Clinical-instrumental Characterization on the Ultrasound and Biological Characteristics of Atypical Endometriosis.

Run by Casa di Cura Dott. Pederzoli · NCT07816133 · Data updated 2026-11-12

Researchers will look at how endometriotic tissue that looks atypical under the microscope relates to clinical features and ultrasound findings to better separate benign from potentially atypical lesions.

Quick facts

Study typeObservational
Ages18 Years and up
SexWomen only
Enrollment200 (estimated)
SponsorCasa di Cura Dott. Pederzoli
Academic / other
Locations1 site (Peschiera del Garda, Verona)
StatusRecruiting
StartedOctober 2026
Main results expectedJanuary 2029
Study endsJune 2029
Registry record updatedSeptember 11, 2026
Trial IDNCT07816133 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults 18 or older undergoing endometriosis-related surgery or biopsies with available ultrasound data and informed consent.

Probably not a fit

Patients whose lesions remain benign and non-atypical may not experience a direct benefit, though findings may advance knowledge.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study analyzes tissue from patients undergoing laparoscopic surgery for endometriosis or related conditions to characterize histology, immunophenotype, and molecular features. It combines retrospective and prospective data from a single center, with two comparison groups: endometriosis without atypia and neoplasia not associated with endometriosis as controls, and atypical or cancerized endometriosis as cases. Data collection aligns with routine clinical practice and includes ultrasound findings and anatomopathological analyses. The study aims to generate hypotheses about how atypical changes may progress toward malignancy and how ultrasound and molecular markers could aid risk stratification.

Why it matters

Potential benefit: If successful, the study could improve risk stratification and inform future management of endometriosis with atypical features.

How similar studies have gone: Previous research in related areas has reported meaningful insights from combined histology and imaging analyses in endometriosis, though this exact atypical focus is less established.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Age \> 18 years
* Candidate patients for endometriosis surgery with deep endometriosis (intestine, LUS) and/or endometrioma localizations.
* Patients who are candidates for surgery for established or suspected endometrial and/or ovarian neoplasm
* Patients who have performed a level II gynecological ultrasound with an experienced operator in the preoperative process.
* Patients where there is the technical possibility of performing a transvaginal and/or transrectal ultrasound and the patient's willingness to undergo such an investigation.
* Signing of informed consent.

Exclusion Criteria:

* Technical impossibility of performing a transvaginal ultrasound (patient virgo, patient refusal).
* Previous neoplasms
* Patient who does not provide their informed consent.

Where it's running

  • Ospedale P. Pederzoli Casa di Cura Privata S.p.A.
    Peschiera del Garda, Verona, Italy
    Recruiting

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.